Review ArticleReview Article
Open Access

Lymphangiogenesis and colorectal cancer

Ciyou Huang and Yigang Chen
Saudi Medical Journal March 2017, 38 (3) 237-244; DOI: https://doi.org/10.15537/smj.2017.3.16245

References

  1. ↵
    1. Ayman Eldesoky,
    2. Ashraf Shouma,
    3. Yousef Mosaad,
    4. Amira Elhawary
    (2011) Clinical relevance of serum vascular endothelial growth factor and Interleukin-6 in patients with colorectal cancer. Saudi J Gastroenterol 17:170–173.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Du B,
    2. Yang ZY,
    3. Zhong XY,
    4. Fang M,
    5. Yan YR,
    6. Qi GL,
    7. et al.
    (2011) Metastasis-associated protein 1 induces VEGF-C and facilitates lymphangiogenesis in colorectal cancer. World J Gastroenterol 17:1219–1226.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Pepper MS
    (2001) Lymphangiogenesis and tumor metastasis myth or reality? Clin Cancer Res 7:462–468.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Swanson RS,
    2. Compton CC,
    3. Stewart AK,
    4. Bland KI
    (2003) The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 10:65–71.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Compton CC,
    2. Greene FL
    (2004) The staging of colorectal cancer:2004 and beyond. CA Cancer J Clin 54:295–308.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Sundlisæter E,
    2. Dicko A,
    3. Sakariassen PO,
    4. Sondenaa K,
    5. Enger PO,
    6. Bjerkvig R
    (2007) Lymphangiogenesis in colorectal cancer-prognostic and therapeutic aspects. Int J Cancer 121:1401–1409.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Chu AY,
    2. Litzky LA,
    3. Pasha TL,
    4. Acs G,
    5. Zhang PJ
    (2005) Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol 18:105–110.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Yan G,
    2. Zhou XY,
    3. Cai SJ,
    4. Zhang GH,
    5. Peng JJ,
    6. Du X
    (2008) Lymphangiogenic and angiogenic microvessel density in human primary sporadic colorectal carcinoma. World J Gastroenterol 14:101–107.
    OpenUrlPubMed
  9. ↵
    1. Lin M,
    2. Ma SP,
    3. Lin HZ,
    4. Ji P,
    5. Xie D,
    6. Yu JX
    (2010) Intratumoral as well as peritumoral lymphatic vessel invasion correlates with lymph node metastasis and unfavourable outcome in colorectal cancer. Clin Exp Metastasis 27:123–132.
    OpenUrlPubMed
  10. ↵
    1. Gao Y,
    2. Zhong WX,
    3. Mu DB,
    4. Yuan YP,
    5. Zhang YH,
    6. Yu JM,
    7. et al.
    (2008) Distributions of angiogenesis and lymphangiogenesis in gastrointestinal intramucosal tumors. Ann Surg Oncol 15:1117–1123.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Liang P,
    2. Hong JW,
    3. Ubukata H,
    4. Liu HR,
    5. Watanabe Y,
    6. Katano M,
    7. et al.
    (2006) Increased density and diameter of lymphatic microvessels correlate with lymph node metastasis in early stage invasive colorectal carcinoma. Virchows Arch 448:570–575.
    OpenUrlCrossRefPubMedWeb of Science
    1. Saad RS,
    2. Kordunsky L,
    3. Liu YL,
    4. Denning KL,
    5. Kandil HA,
    6. Silverman JF
    (2006) Lymphatic microvessel density as prognostic marker in colorectal cancer. Mod Pathol 19:1317–1323.
    OpenUrlCrossRefPubMedWeb of Science
    1. Omachi T,
    2. Kawai Y,
    3. Mizuno R,
    4. Nomiyama T,
    5. Miyagawa S,
    6. Ohhashi T,
    7. et al.
    (2007) Immunohistochemical demonstration of proliferating lymphatic vessels in colorectal carcinoma and its clinicopathological significance. Cancer Lett 246:167–172.
    OpenUrlCrossRefPubMedWeb of Science
    1. Kaneko I,
    2. Tanaka S,
    3. Oka S,
    4. Yoshida S,
    5. Hiyama T,
    6. Arihiro K,
    7. et al.
    (2007) Immunohistochemical molecular markers as predictors of curability of endoscopically resected submucosal colorectal cancer. World J Gastroenterol 13:3829–3835.
    OpenUrlPubMed
    1. Duff SE,
    2. Jeziorska M,
    3. Kumar S,
    4. Haboubi N,
    5. Sherlock D,
    6. O’Dwyer ST,
    7. et al.
    (2007) Lymphatic vessel density, microvessel density and lymphangiogenic growth factor expression in colorectal cancer. Colorectal Dis 9:793–800.
    OpenUrlCrossRefPubMedWeb of Science
    1. Holmqvist A,
    2. Gao J,
    3. Adell G,
    4. Carstensen J,
    5. Sun XF
    (2010) The location of lymphangiogenesis is an independent prognostic factor in rectal cancers with or without preoperative radiotherapy PDF.
    1. Matsumoto K,
    2. Nakayama Y,
    3. Inoue Y,
    4. Minagawa N,
    5. Katsuki T,
    6. Shibao K,
    7. et al.
    (2007) Lymphatic microvessel density is an independent prognostic factor in colorectal cancer. Dis Colon Rectum 50:308–314.
    OpenUrlCrossRefPubMedWeb of Science
    1. Longatto-Filho A,
    2. Pinheiro C,
    3. Ferreira L,
    4. Scapulatempo C,
    5. Alves VA,
    6. Baltazar F,
    7. et al.
    (2008) Peritumoural, but not intratumoural, lymphatic vessel density and invasion correlate with colorectal carcinoma poor-outcome markers. Virchows Archiv 452:133–138.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Gao J,
    2. Knutsen A,
    3. Arbman G,
    4. Carstensen J,
    5. Frånlund B,
    6. Sun XF
    (2009) Clinical and biological significance of angiogenesis and lymphangiogenesis in colorectal cancer. Dig Liver Dis 41:116–1122.
    OpenUrlPubMed
  20. ↵
    1. Barresi V,
    2. Reggiani-Bonetti L,
    3. Di Gregorio C,
    4. De Leon MP,
    5. Barresi G
    (2011) Lymphatic vessel density and its prognostic value in stage I colorectal carcinoma. J Clin Pathol 64:6–12.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Fogt F,
    2. Zimmerman R,
    3. Ross H,
    4. Daly T,
    5. Gausas R
    (2004) Identification of lymphatic vessels in malignant, adenomatous and normal colonic mucosa using the novel immunostain D2-40. Oncology Reports 11:47–50.
    OpenUrlPubMedWeb of Science
  22. ↵
    1. Weidner N,
    2. Semple JP,
    3. Welch WR,
    4. Folkman J
    (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324:1–8.
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    1. Moreira LR,
    2. Schenka AA,
    3. Latuf-Filho P,
    4. Penná AL,
    5. Lima CS,
    6. Soares FA,
    7. et al.
    (2011) Immunohistochemical analysis of vascular density and area in colorectal carcinoma using different markers and comparison with clinicopathologic prognostic factors. Tumour Biol 32:527–534.
    OpenUrlPubMed
  24. ↵
    1. Moreira L,
    2. Schenka A,
    3. Latuf Filho P,
    4. Lima C,
    5. Trevisan M,
    6. Vassallo J
    (2009) Comparison of blood neoangiogenesis and lymphatic vascularization in colorectal adenomas from patients with and without concomitant colorectal cancer. Brazilian Journal of Medical and Biological Research 42:593–598.
    OpenUrlPubMed
  25. ↵
    1. Sundlisaeter E,
    2. Rosland GV,
    3. Hertel JK,
    4. Sakariassen PO,
    5. Almås B,
    6. Dicko A,
    7. et al.
    (2009) Increased lymphatic vascular density is seen before colorectal cancers reach stage II and growth factor FGF 2 is downregulated in tumor tissue compared with normal mucosa. Apmis 117:212–221.
    OpenUrlPubMed
  26. ↵
    1. Kruschewski M,
    2. Rieger H,
    3. Pohlen U,
    4. Hotz HG,
    5. Buhr HJ
    (2007) Risk factors for clinical anastomotic leakage and postoperative mortality in elective surgery for rectal cancer. Int J Colorectal Dis 22:919–927.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Chen W,
    2. Li Y,
    3. Liao Z,
    4. Lin G,
    5. Cai G,
    6. Lin K,
    7. et al.
    (2011) Active lymphangiogenesis is a major risk factor for anastomotic leakage following sphincter sparing resection of rectal cancer. J Surg Oncol 104:493–498.
    OpenUrlPubMed
  28. ↵
    1. Doekhie FS,
    2. Morreau H,
    3. de Bock GH,
    4. Speetjens FM,
    5. Dekker-Ensink NG,
    6. Putter H,
    7. et al.
    (2008) Sialyl Lewis X expression and lymphatic microvessel density in primary tumors of node-negative colorectal cancer patients predict disease recurrence. Cancer Microenviron 1:141–151.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Levin B,
    2. Lieberman DA,
    3. McFarland B,
    4. Smith RA,
    5. Brooks D,
    6. Andrews KS,
    7. et al.
    (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 58:130–160.
    OpenUrlCrossRefPubMedWeb of Science
    1. Tsirlis TD,
    2. Papastratis G,
    3. Masselou K,
    4. Tsigris C,
    5. Papachristodoulou A,
    6. Kostakis A,
    7. et al.
    (2008) Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance? World J Gastroenterol 14:2691–2701.
    OpenUrlCrossRefPubMedWeb of Science
    1. Jinbo J,
    2. Xuemei L,
    3. Weidong Z,
    4. Min Z,
    5. Nanhai S
    (2006) Relationship of vascilar endothelial growth factor-C and lymphangiogenesi with the development and prognosis of colon cancer. Chin J Gastrointest Surg 8:516–519.
    OpenUrl
    1. Fan Y,
    2. Li G,
    3. Huang G,
    4. Li X
    (2006) [Clinical significance of detection on lymphatic microvessel, lymphatic microvessel density and vascular endothelial growth factor-C in patients with colorectal carcinoma]. Zhonghua Wei Chang Wai Ke Za Zhi 9:477–482, Chinese.
    OpenUrlPubMed
  33. ↵
    1. Li Z,
    2. Zhang G,
    3. Hu Z,
    4. Fan Y
    (2009) [Expression of lymphatic vessel endothelial hyaluronan receptor-1 in human colorectal cancer and its clinical significance]. Zhonghua Wei Chang Wai Ke Za Zhi 12:511–514, Chinese.
    OpenUrlPubMed
  34. ↵
    1. Yang X,
    2. Li L,
    3. Pan Z,
    4. Zhou Z,
    5. Wan D
    (2006) [Lymphatic vessel density in Dukes’ B rectal carcinoma and its correlation to prognosis]. Ai Zheng 25:749–752, Chinese.
    OpenUrlPubMed
  35. ↵
    1. Chen Y,
    2. Yan J,
    3. Wang Z,
    4. Yu S,
    5. Yuan Z,
    6. Yang C,
    7. et al.
    (2013) A meta-analysis of the relationship between lymphatic microvessel density and the survival of patient with colorectal cancer. Lymphology 46:42–51.
    OpenUrl
  36. ↵
    1. Chen W,
    2. Chen M,
    3. Liao Z,
    4. Wang Y,
    5. Zhan Q,
    6. Cai G
    (2009) Lymphatic vessel density as predictive marker for the local recurrence of rectal cancer. Dis Colon Rectum 52:513–519.
    OpenUrlPubMed
  37. ↵
    1. Noda E,
    2. Maeda K,
    3. Inoue T,
    4. Nishihara T,
    5. Nishiguchi Y,
    6. Ohira M,
    7. et al.
    (2007) Predictive value of vascular endothelial growth factor-C expression for local recurrence of rectal carcinoma. Oncol Rep 17:1327–1331.
    OpenUrlPubMed
  38. ↵
    1. Hanahan D,
    2. Weinberg RA
    (2011) Hallmarks of cancer: the next generation. Cell 144:646–674.
    OpenUrlCrossRefPubMedWeb of Science
  39. ↵
    1. Saharinen P,
    2. Tammela T,
    3. Karkkainen MJ,
    4. Alitalo K
    (2004) Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 25:387–395.
    OpenUrlCrossRefPubMedWeb of Science
  40. ↵
    1. Stacker SA,
    2. Caesar C,
    3. Baldwin ME,
    4. Thornton GE,
    5. Williams RA,
    6. Prevo R,
    7. et al.
    (2001) VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7:186–191.
    OpenUrlCrossRefPubMedWeb of Science
  41. ↵
    1. Lohela M,
    2. Bry M,
    3. Tammela T,
    4. Alitalo K
    (2009) VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 21:154–165.
    OpenUrlCrossRefPubMedWeb of Science
  42. ↵
    1. Achen M,
    2. Mann G,
    3. Stacker S
    (2006) Targeting lymphangiogenesis to prevent tumour metastasis. Br J Cancer 94:1355–1360.
    OpenUrlCrossRefPubMedWeb of Science
  43. ↵
    1. Su JL,
    2. Yen CJ,
    3. Chen PS,
    4. Chuang SE,
    5. Hong CC,
    6. Kuo IH,
    7. et al.
    (2007) The role of the VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer 96:541–545.
    OpenUrlCrossRefPubMedWeb of Science
  44. ↵
    1. Burton JB,
    2. Priceman SJ,
    3. Sung JL,
    4. Brakenhielm E,
    5. An DS,
    6. Pytowski B,
    7. et al.
    (2008) Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis. Cancer Res 68:7828–7837.
    OpenUrlAbstract/FREE Full Text
  45. ↵
    1. Krishnan J,
    2. Kirkin V,
    3. Steffen A,
    4. Hegen M,
    5. Weih D,
    6. Tomarev S,
    7. et al.
    (2003) Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats. Cancer Res 63:713–722.
    OpenUrlAbstract/FREE Full Text
  46. ↵
    1. Sun S,
    2. Qiu XS
    (2013) Cancer stem cells and tumor metastasis. J Cancer Res Ther 9(Suppl):S150–S152.
    OpenUrl
  47. ↵
    1. Hooper JE,
    2. Scott MP
    (2005) Communicating with hedgehogs. Nat Rev Mol Cell Biol 6:306–317.
    OpenUrlCrossRefPubMedWeb of Science
  48. ↵
    1. Yoo YA,
    2. Kang MH,
    3. Lee HJ,
    4. Kim B-h,
    5. Park JK,
    6. Kim HK,
    7. et al.
    (2011) Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer. Cancer Res 71:7061–7070.
    OpenUrlAbstract/FREE Full Text
  49. ↵
    1. Bailey JM,
    2. Mohr AM,
    3. Hollingsworth MA
    (2009) Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene 28:3513–3525.
    OpenUrlCrossRefPubMedWeb of Science
  50. ↵
    1. Wiig H,
    2. Keskin D,
    3. Kalluri R
    (2010) Interaction between the extracellular matrix and lymphatics: consequences for lymphangiogenesis and lymphatic function. Matrix Biol 29:645–656.
    OpenUrlCrossRefPubMed
  51. ↵
    1. Gerli R,
    2. Solito R,
    3. Weber E,
    4. Agliano M
    (2000) Specific adhesion molecules bind anchoring filaments and endothelial cells in human skin initial lymphatics. Lymphology 33:148–157.
    OpenUrlPubMedWeb of Science
  52. ↵
    1. Wiig H,
    2. Gyenge C,
    3. Iversen PO,
    4. Gullberg D,
    5. Tenstad O
    (2008) The role of the extracellular matrix in tissue distribution of macromolecules in normal and pathological tissues: potential therapeutic consequences. Microcirculation 15:283–296.
    OpenUrlCrossRefPubMedWeb of Science
  53. ↵
    1. Tammela T,
    2. Alitalo K
    (2010) Lymphangiogenesis: Molecular mechanisms and future promise. Cell 140:460–476.
    OpenUrlCrossRefPubMedWeb of Science
  54. ↵
    1. Wissmann C,
    2. Detmar M
    (2006) Pathways targeting tumor lymphangiogenesis. Clin Cancer Res 12:6865–6868.
    OpenUrlAbstract/FREE Full Text
  55. ↵
    1. Kane RC,
    2. Farrell AT,
    3. Saber H,
    4. Tang S,
    5. Williams G,
    6. Jee JM,
    7. et al.
    (2006) Sorafenib for the treatment of advanced renal cell carcinoma. Clin Cancer Res 12:7271–7278.
    OpenUrlAbstract/FREE Full Text
  56. ↵
    1. Los M,
    2. Roodhart JM,
    3. Voest EE
    (2007) Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer. Oncologist 12:443–450.
    OpenUrlAbstract/FREE Full Text
  57. ↵
    1. Busby JE,
    2. Kim SJ,
    3. Yazici S,
    4. Nakamura T,
    5. Kim JS,
    6. He J,
    7. et al.
    (2006) Therapy of multidrug resistant human prostate tumors in the prostate of nude mice by simultaneous targeting of the epidermal growth factor receptor and vascular endothelial growth factor receptor on tumor associated endothelial cells. Prostate 66:1788–1798.
    OpenUrlCrossRefPubMed
  58. ↵
    1. KaradayıN Kandemır NO,
    2. Yavuzer D,
    3. Korkmaz T,
    4. Gecmen G,
    5. Kokturk F
    (2013) Inducible nitric oxide synthase expression in gastric adenocarcinoma: impact on lymphangiogenesis and lymphatic metastasis. Diagn Pathol 8:151.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section